Isabel Centeno

Licensed Psychologist | PsychoOncologist | Elisabeth Kübler Faculty member | Cancer Advocate | CoAuthor Research in Creative Arts Therapies | Travesias De Tinta

[Isabel Centeno @IsabelCentenoS]

Check out this moment from Envious, starting at 0:57.

https://t.co/TP3x2DQX1L

[Isabel Centeno @IsabelCentenoS]

Cree esta guía para esos momentos en que de un momento a otro todo cambia sin aparente explicación.
Cree esta guía de escritura para lo que no se dijo. La encuentras en @Gumroad https://t.co/cLNnxzXiI3

[IPOS @IPOSPsychoOncol]

Webinar: Expert Session FORWard Interest Group Featuring Ben Smith (Australia) — May 18, 2026

Dr. Ben Smith has a particular interest in fear of cancer recurrence, digital health interventions and underserved populations impacted by cancer.

Read more https://t.co/eykzyZpI4t

[IPOS @IPOSPsychoOncol]

For the 8th consecutive year, @IPOSPsychoOncol has exceeded the milestone of 600+ members from across 124 countries around the World!

Not a current member of IPOS for 2026? THERE IS STILL TIME!

Read more by going to https://t.co/77ONXTmuU9

[Valentina Gambardella @ValeGambardella]

👏 Great job by Dr. @TarazonaNoelia presenting the highlights on lower GI tumors at #ESMO25, from 💊 advances in CRC treatment to 🧬 novel biomarkers and 📊 trial results.

[Isabel Centeno @IsabelCentenoS]

Congratulations!!!!

[Anwaar Saeed @AnwaarSaeed3]

A dream realized! 🎉 I presented the STELLAR-303 Phase 3 results today at #ESMO2025 — simultaneously published in The Lancet! Trial met its OS primary endpoint in MSS CRC. From CAMILLA to now, 8 years of relentless work. Full circle. A new era begins. Grateful. 🙏✨@OncoAlert

[Isabel Centeno @IsabelCentenoS]

Gracias a @elnorte por tomar en cuenta mis palabras. #cancerDeMama

[Isabel Centeno @IsabelCentenoS]

Lucha en rosa - 19 de Oct.
Periódico completo:
https://t.co/Eg5Mo8HvRg

[Isabel Centeno @IsabelCentenoS]

https://t.co/C2yL5cR7bv

[Isabel Centeno @IsabelCentenoS]

Happy to share our recent paper @christinemaheu Systematic Review of Fear of Cancer Recurrence Patient-Reported Outcome Measures: Evaluating Methodological Quality and Measurement Properties Using the COSMIN Checklist https://t.co/VIZ1ZQxaBE #mdpihealthcare @HealthcareMDPI_

[IPOS @IPOSPsychoOncol]

Special Message from the Journal of Psychosocial Oncology Research and Practice (JPORP) Advisory Board member, Melba D’Souza - the official Publication of IPOS https://t.co/O4hQfcISXb

Learn more about JPORP by going to https://t.co/zCLLwm5yOL

[Isabel Centeno @IsabelCentenoS]

%!(EXTRA string=Centro De Urología Avanzada) https://t.co/CNm0N4xpTQ

[Isabel Centeno @IsabelCentenoS]

https://t.co/30bR9UYlCK

[Isabel Centeno @IsabelCentenoS]

%!(EXTRA string=Centro De Urología Avanzada) https://t.co/jBr18lJQGz

[Isabel Centeno @IsabelCentenoS]

Sigo pensando y conversando sobre la importancia del apoyo psicooncológico https://t.co/v339HerDkJ

[Isabel Centeno @IsabelCentenoS]

#psicooncología https://t.co/SxFLwJKAfn

[Isabel Centeno @IsabelCentenoS]

Ep 67: ¿CÓMO ACOMPAÑAR EN UN DIAGNÓSTICO DE CÁNCER? Isabel Centeno https://t.co/oFPmXy6Gvi vía @YouTube

#psicooncología
#oncogeriatría

[Isabel Centeno @IsabelCentenoS]

#miedoalarecurrencia https://t.co/bhgsKRt3UL

[Isabel Centeno @IsabelCentenoS]

#miedoalarecurrencia https://t.co/bhgsKRt3UL